Importantly, the Bcl-X(L)-specific T cells did not only lyse in vitro generated tumor cell lines, but in addition lysed ex vivo enriched AML cells demonstrating that killing is not restricted to long-term cell lines. Here, BCL2L1 is linked to acute myeloid leukemia.